Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 3742495)

1.

Phase II study of spirogermanium in metastatic prostate cancer.

Dexeus FH, Logothetis C, Samuels ML, Hossan B.

Cancer Treat Rep. 1986 Sep;70(9):1129-30. No abstract available.

PMID:
3742495
2.

Phase II study of spirogermanium in advanced breast cancer.

Kuebler JP, Tormey DC, Harper GR, Chang YC, Khandekar JD, Falkson G.

Cancer Treat Rep. 1984 Dec;68(12):1515-6. No abstract available.

PMID:
6509457
3.

[Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].

Bui NB, Chauvergne J, Brunet R, Richaud P, Hoerni B, Lagarde C, Le Guillou M.

Bull Cancer. 1986;73(1):65-7. French.

PMID:
3779124
4.

Phase I clinical trial of spirogermanium.

Schein PS, Slavik M, Smythe T, Hoth D, Smith F, Macdonald JS, Woolley PV.

Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1051-6.

PMID:
7459890
5.

Phase II study of spirogermanium in the treatment of metastatic breast cancer.

Pinnamaneni K, Yap HY, Legha SS, Blumenschein GR, Bodey GP.

Cancer Treat Rep. 1984 Sep;68(9):1197-8. No abstract available.

PMID:
6478457
6.

A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study.

Eisenhauer E, Kerr I, Bodurtha A, Iscoe N, McCulloch P, Pritchard K, Quirt I.

Invest New Drugs. 1985;3(3):303-5.

PMID:
4066224
7.

Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.

Dhingra HM, Umsawasdi T, Chiuten DF, Murphy WK, Holoye PY, Spitzer G, Valdivieso M.

Cancer Treat Rep. 1986 May;70(5):673-4. No abstract available.

PMID:
3708617
8.

Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.

Schulman P, Davis RB, Rafla S, Green M, Henderson E.

Cancer Treat Rep. 1984 Oct;68(10):1305-6. No abstract available.

PMID:
6525606
9.

Phase II trial of spirogermanium for treatment of advanced breast cancer.

Falkson G, Falkson HC.

Cancer Treat Rep. 1983 Feb;67(2):189-90. No abstract available.

PMID:
6825129
10.

Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.

Budman DR, Ginsberg S, Perry M, Weinberg V, Schein P, Hanson J, Coleman M, Wood W.

Cancer Treat Rep. 1982 Aug;66(8):1667-8. No abstract available.

PMID:
7105058
11.

Phase II evaluation of spirogermanium in advanced ovarian carcinoma.

Brenner DE, Jones HW, Rosenshein NB, Forastiere A, Dillon M, Grumbine F, Tipping S, Burnett L, Greco FA, Wiernik PH.

Cancer Treat Rep. 1983 Feb;67(2):193-4. No abstract available.

PMID:
6825131
12.

Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.

Weiselberg L, Budman DR, Schulman P, Vinciguerra V, Degnan TJ, Pasmantier M.

Cancer Treat Rep. 1982 Aug;66(8):1675-6. No abstract available.

PMID:
7201885
13.

Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.

Boros L, Tsiatis AA, Neiman RS, Mann RB, Glick JH.

Cancer Treat Rep. 1986 Jul;70(7):917-8. No abstract available.

PMID:
3719586
14.

Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.

Slavik M, Blanc O, Davis J.

Invest New Drugs. 1983;1(3):225-34.

PMID:
6678870
15.

Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.

Kavanagh JJ, Saul PB, Copeland LJ, Gershenson DM, Krakoff IH.

Cancer Treat Rep. 1985 Jan;69(1):139-40. No abstract available.

PMID:
3967257
16.

A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study.

Eisenhauer E, Quirt I, Connors JM, Maroun J, Skillings J.

Invest New Drugs. 1985;3(3):307-10.

PMID:
4066225
17.

Phase II trial of spirogermanium in central nervous system tumors: a Southwest Oncology Group Study.

Goodwin JW, Crowley J, Tranum B, Vance R, Slavik M, Balcerzak S, Hacker D.

Cancer Treat Rep. 1987 Jan;71(1):99-100. No abstract available.

PMID:
3791276
18.

Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.

Brenner DE, Rosenshein NB, Dillon M, Jones HW, Forastiere A, Tipping S, Burnett LS, Greco FA, Wiernik PH.

Cancer Treat Rep. 1985 Apr;69(4):457-8. No abstract available.

PMID:
3995514
19.

Phase II study of spirogermanium in advanced ovarian malignancy.

Tropé C, Mattsson W, Gynning I, Johnsson JE, Sigurdsson K, Orbert B.

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):119-20.

PMID:
6261944
20.

Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group Study.

Saiers JH, Blumenstein B, Slavik M, Costanzi JH, Crawford ED.

Cancer Treat Rep. 1987 Dec;71(12):1305-6. No abstract available.

PMID:
3690546
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk